(Q53536436)

English

Severity of non-alcoholic fatty liver disease is associated with high systemic levels of tumor necrosis factor alpha and low serum interleukin 10 in morbidly obese patients.

scientific article published on 18 April 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/25894568

Severity of non-alcoholic fatty liver disease is associated with high systemic levels of tumor necrosis factor alpha and low serum interleukin 10 in morbidly obese patients. (English)

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/25894568

0 references

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

based on heuristic

inferred from title

José Manuel Fragoso

7

object named as

José Manuel Fragoso

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/25894568

author name string

Gabriela Paredes-Turrubiarte

1

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/25894568

Antonio González-Chávez

2

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/25894568

Ruy Pérez-Tamayo

3

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/25894568

Beatriz Y Salazar-Vázquez

4

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/25894568

Vito S Hernández

5

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/25894568

Nayeli Garibay-Nieto

6

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/25894568

Galileo Escobedo

8

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/25894568

publication date

18 April 2015

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/25894568

Clinical and Experimental Medicine

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/25894568

16

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/25894568

2

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/25894568

193-202

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/25894568

https://scigraph.springernature.com/pub.10.1007/s10238-015-0347-4

0 references

Does global obesity represent a global public health challenge?

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Association between class III obesity (BMI of 40-59 kg/m2) and mortality: a pooled analysis of 20 prospective studies

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

The distinction of metabolically 'healthy' from 'unhealthy' obese individuals

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Non-alcoholic steatohepatitis in morbidly obese patients

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Serum IL-12 is increased in Mexican obese subjects and associated with low-grade inflammation and obesity-related parameters

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Hyperleptinemia is associated with parameters of low-grade systemic inflammation and metabolic dysfunction in obese human beings

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Efficacy of Tumor Necrosis Factor and Interleukin-10 Analysis in the Follow-up of Nonalcoholic Fatty Liver Disease Progression

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Metabolic syndrome, prediabetes, and brain abnormalities on mri in patients with manifest arterial disease: the SMART-MR study

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Prevalence and Trends in Obesity Among US Adults, 1999-2000

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Clinical practice. Overweight children and adolescents

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Etiopathogenesis of nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Mexican American children have differential elevation of metabolic biomarkers proportional to obesity status.

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Metabolic syndrome in obese Caucasian children: prevalence using WHO-derived criteria and association with nontraditional cardiovascular risk factors.

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Metabolic syndrome risk factors in overweight, obese, and extremely obese Brazilian adolescents

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Metabolic effects of bariatric surgery in insulin-sensitive morbidly obese subjects

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Are there still healthy obese patients?

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

GI epidemiology: nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Are there persons who are obese, but metabolically healthy?

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Bariatric surgery significantly decreases the prevalence of type 2 diabetes mellitus and pre-diabetes among morbidly obese multiethnic adults: long-term results

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Effects of exercise on C-reactive protein, inflammatory cytokine and adipokine in patients with type 2 diabetes: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Cytokine abnormalities in the etiology of the cardiometabolic syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Spleen-derived interleukin-10 downregulates the severity of high-fat diet-induced non-alcoholic fatty pancreas disease

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Targeting curcusomes to inflammatory dendritic cells inhibits NF-κB and improves insulin resistance in obese mice

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Potential mechanisms by which polyphenol-rich grapes prevent obesity-mediated inflammation and metabolic diseases

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Inhibition of soluble epoxide hydrolase attenuates high-fat-diet-induced hepatic steatosis by reduced systemic inflammatory status in mice

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Clinicopathological significance of oxidative cellular damage in non-alcoholic fatty liver diseases

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Mechanisms of Liver Injury: An Overview

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Mechanisms of hepatotoxicity

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Triglycerides potentiate the inflammatory response in rat Kupffer cells.

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

CYP2E1-dependent and leptin-mediated hepatic CD57 expression on CD8+ T cells aid progression of environment-linked nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Mechanisms of Disease: hepatic steatosis in type 2 diabetes--pathogenesis and clinical relevance

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

The regulation of IL-10 production by immune cells

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Pro- and anti-inflammatory cytokines in steatosis and steatohepatitis

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Interleukin-10 is a protective factor against diet-induced insulin resistance in liver

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Endogenous interleukin-10 protects against hepatic steatosis but does not improve insulin sensitivity during high-fat feeding in mice.

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Prevalence and associated metabolic factors of fatty liver disease in the elderly

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Vitamin E-gene interactions in aging and inflammatory age-related diseases: implications for treatment. A systematic review

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Effects of taxifolin on the activity of angiotensin-converting enzyme and reactive oxygen and nitrogen species in the aorta of aging rats and rats treated with the nitric oxide synthase inhibitor and dexamethasone

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Nonalcoholic Fatty Liver Disease in Severely Obese Subjects

1 reference

https://api.crossref.org/works/10.1007%2FS10238-015-0347-4

21 January 2018

Influence of lifestyle-related diseases and age on the development and progression of non-alcoholic fatty liver disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25894568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of bariatric surgery on patient HRQOL and sexual health during a 1-year postoperative period

1 reference

https://pubmed.ncbi.nlm.nih.gov/25894568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Can bariatric surgery improve cardiovascular risk factors in the metabolically healthy but morbidly obese patient?

1 reference

https://pubmed.ncbi.nlm.nih.gov/25894568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The obese healthy paradox: is inflammation the answer?

1 reference

https://pubmed.ncbi.nlm.nih.gov/25894568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor necrosis factor antibodies reduce hepatic steatosis during total parenteral nutrition and bowel rest in the rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/25894568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complications of obesity in adults: a short review of the literature

1 reference

https://pubmed.ncbi.nlm.nih.gov/25894568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictive factors for nonalcoholic steatohepatitis (NASH) in patients with nonalcoholic fatty liver disease (NAFLD).

1 reference

https://pubmed.ncbi.nlm.nih.gov/25894568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonalcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25894568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Prevalence of obesity in Mexican adults 2000-2012].

1 reference

https://pubmed.ncbi.nlm.nih.gov/25894568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Therapeutic efficacy and mechanisms of quercetin in a rat model of nonalcoholic fatty liver disease].

1 reference

https://pubmed.ncbi.nlm.nih.gov/25894568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/25894568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mapping of the circulating metabolome reveals α-ketoglutarate as a predictor of morbid obesity-associated non-alcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25894568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Index of central obesity as a parameter to replace waist circumference for the definition of metabolic syndrome in predicting cardiovascular disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25894568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association between metabolic syndrome and the development of non-alcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25894568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[The role of oxidative stress in skin aging]

1 reference

https://pubmed.ncbi.nlm.nih.gov/25894568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10238-015-0347-4

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/25894568

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/25894568

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53536436&oldid=1531254066"